|
| 34986074 | Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease. | Arch Physiol Biochem | 2024 |
| 37625673 | When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? | Autoimmun Rev | 2024 |
| 37550217 | Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis. | Nephrol Dial Transplant | 2024 |
| 34850136 | Klotho in kidney diseases: a crosstalk between the renin-angiotensin system and endoplasmic reticulum stress. | Nephrol Dial Transplant | 2023 |
| 37915910 | Incidence and prognosis of acute kidney injury versus acute kidney disease among 71Â 041 inpatients. | Clin Kidney J | 2023 |
| 37744356 | No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice. | Front Immunol | 2023 |
| 37944989 | Immunonephrology-innovations that (will) improve clinical practice. | Nephrol Dial Transplant | 2023 |
| 37887284 | Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis. | Cells | 2023 |
| 37739620 | Corrigendum to "International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology." Kidney International, 2023;104:36-45. | Kidney Int | 2023 |
| 37580128 | A Rapid Sterility Method Using Solid Phase Cytometry for Cell-Based Preparations and Culture Media and Buffers. | PDA J Pharm Sci Technol | 2023 |
| 37543287 | From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. | Autoimmun Rev | 2023 |
| 37676696 | Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy. | FASEB J | 2023 |
| 37868987 | Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes account for organ injury, regeneration or atrophy. | Front Immunol | 2023 |
| 37564649 | Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis. | Front Immunol | 2023 |
| 35840344 | Challenges Encountered in the Implementation of Bio-Fluorescent Particle Counting Systems as a Routine Microbial Monitoring Tool. | PDA J Pharm Sci Technol | 2023 |
| 37218714 | The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC). | Nephrol Dial Transplant | 2023 |
| 37218706 | CKD therapy to improve outcomes of immune-mediated glomerular diseases. | Nephrol Dial Transplant | 2023 |
| 37190141 | Inflammatory Networks in Renal Cell Carcinoma. | Cancers (Basel) | 2023 |
| 36951893 | Prediction of Male Coronary Artery Bypass Grafting Outcomes Using Body Surface Area Weighted Left Ventricular End-diastolic Diameter: Multicenter Retrospective Cohort Study. | Interact J Med Res | 2023 |
| 37423985 | A "Kidney-on-the-Chip" Model Composed of Primary Human Tubular, Endothelial, and White Blood Cells. | Methods Mol Biol | 2023 |
| 37175735 | Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence. | Int J Mol Sci | 2023 |
| 37001603 | Both hyperglycemia and hyperuricemia aggravate acute kidney injury during cholesterol embolism syndrome despite opposite effects on kidney infarct size. | Kidney Int | 2023 |
| 37164940 | Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations. | Nephrol Dial Transplant | 2023 |
| 37428955 | Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice. | J Am Soc Nephrol | 2023 |
| 37093522 | Lupus Nephritis: New and Emerging Biologic and Targeted Therapies. | BioDrugs | 2023 |
| 37463054 | Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial. | Nephrol Dial Transplant | 2023 |
| 37261000 | Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications. | Clin Kidney J | 2023 |
| 36753701 | A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases. | J Am Soc Nephrol | 2023 |
| 36409755 | Role of endoplasmic reticulum stress and autophagy in the transition from acute kidney injury to chronic kidney disease. | J Cell Physiol | 2023 |
| 36857499 | Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery. | J Am Soc Nephrol | 2023 |
| 36881727 | Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG). | Nephrol Dial Transplant | 2023 |
| 36586092 | Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease. | Mol Cell Biochem | 2023 |
| 36843922 | How to use COVID-19 antiviral drugs in patients with chronic kidney disease. | Front Pharmacol | 2023 |
| 36608832 | The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention. | Transpl Immunol | 2023 |
| 36509391 | Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins. | Drug Discov Today | 2023 |
| 36830959 | Minimal Collagen-Binding Epitope of Glycoprotein VI in Human and Mouse Platelets. | Biomedicines | 2023 |
| 36635359 | Glomerulonephritis: immunopathogenesis and immunotherapy. | Nat Rev Immunol | 2023 |
| 36630913 | T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis. | Immunity | 2023 |
| 36069913 | What should European nephrology do with the new CKD-EPI equation? | Nephrol Dial Transplant | 2023 |
| 36102665 | Intravenous Glu-plasminogen attenuates cholesterol crystal embolism-induced thrombotic angiopathy, acute kidney injury and kidney infarction. | Nephrol Dial Transplant | 2023 |
| 36379594 | Multisite Qualification of an Automated Incubator and Colony Counter for Environmental and Bioburden Applications in Pharmaceutical Microbiology. | PDA J Pharm Sci Technol | 2023 |
| 36253529 | Author Correction: Skeletal and extraskeletal disorders of biomineralization. | Nat Rev Endocrinol | 2023 |
| 35975848 | Diabetes and Cardiorenal Complications: A Clinical Review of Existing Therapies and Novel Combinations, Focusing on SGLT2 Inhibitors. | Curr Diabetes Rev | 2023 |
| 34888694 | The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021. | Nephrol Dial Transplant | 2023 |
| 32223569 | Crosstalk between kidney and liver in non-alcoholic fatty liver disease: mechanisms and therapeutic approaches. | Arch Physiol Biochem | 2022 |
| 35443244 | GDF15 Suppresses Lymphoproliferation and Humoral Autoimmunity in a Murine Model of Systemic Lupus Erythematosus. | J Innate Immun | 2022 |
| 35651717 | Drug-induced CYP induction as therapy for tacrolimus intoxication. | Clin Nephrol Case Stud | 2022 |
| 35704060 | Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease. | J Mol Med (Berl) | 2022 |
| 35728879 | Predicting Future Outcomes from Kidney Biopsies with MCD/FSGS Lesions: Opportunities and Limitations. | J Am Soc Nephrol | 2022 |
| 35578027 | Skeletal and extraskeletal disorders of biomineralization. | Nat Rev Endocrinol | 2022 |